Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 12, 2012, Pages 1410-1417

  Leja, Marcis ^a,b,d   Cine, Eva ^a   Rudzite, Dace ^a,b   Vilkoite, Ilona ^a   Huttunen, Teppo ^e   Daugule, Ilva ^a   Rumba Rozenfelde, Ingrida ^a   Pimanov, Sergey ^f   Liepniece Karele, Inta ^a,b   Pahomova, Jelena ^a   Purmalis, Karlis ^a   Eglitis, Janis ^a,b   Pirags, Valdis ^a,c   Dzerve, Vilnis ^a   Erglis, Andrejs ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

^b RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^c PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^d Digestive Diseases Centre GASTRO   (Latvia)

^e 4Pharma Ltd   (Finland)

^f VITEBSK STATE MEDICAL UNIVERSITY   (Belarus)

Author keywords

ABC method; atrophy; Helicobacter pylori; Latvia; pepsinogen; prevalence

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PEPSINOGEN;

ADULT; ARTICLE; ATROPHIC GASTRITIS; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HELICOBACTER INFECTION; HUMAN; LATVIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LATVIA; LINEAR MODELS; MALE; MIDDLE AGED; PEPSINOGEN A; PEPSINOGEN C; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84869452694     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283583ca5     Document Type: Article

References (42)

1. De Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134:945-952.
2. Agreus L, Kuipers EJ, Kupcinskas L, Malfertheiner P, Di Mario F, Leja M, et al. Rationale in diagnosis and screening of atrophic gastritis with stomachspecific plasma biomarkers. Scand J Gastroenterol 2012; 47:136-147.
3. Lunet N, Barros H. Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer 2003; 106:953-960.
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer; Available at: http://globocan.iarc.fr. [Accessed 22 December 2011]; 2010.
5. Maaroos HI. Helicobacter pylori infection in Estonian population: is it a health problem? Ann Med 1995; 27:613-616.
6. Oona M, Utt M, Nilsson I, Uibo O, Vorobjova T, Maaroos HI. Helicobacter pylori infection in children in Estonia: decreasing seroprevalence during the 11-year period of profound socioeconomic changes. Helicobacter 2004; 9:233-241.
7. Daugule I, Rumba I, Lindkvist P, Bergstrom M, Ejderhamn J. A relatively low prevalence of Helicobacter pylori infection in a healthy paediatric population in Riga, Latvia: a cross-sectional study. Acta Paediatr 2001; 90:1199-1201.
8. Oleastro M, Pelerito A, Nogueira P, Benoliel J, Santos A, Cabral J, et al. Prevalence and incidence of Helicobacter pylori infection in a healthy pediatric population in the Lisbon area. Helicobacter 2011; 16:363-372.
9. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44:74-94.
10. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109:138-143.
11. Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther 1999; 13 (Suppl 1):3-11.
12. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol 2008; 43:1448-1455.
13. Korstanje A, van Eeden S, Offerhaus JA,Waltman FL, Hartog G, Roelandse FW, et al. Comparison between serology and histology in the diagnosis of advanced gastric body atrophy: a study in a Dutch primary community. J Clin Gastroenterol 2008; 42:18-22.
14. Lomba-Viana R, Dinis-Ribeiro M, Fonseca F, Vieira AS, Bento MJ, Lomba-Viana H. Serum pepsinogen test for early detection of gastric cancer in a European country. Eu J Gastroenterol Hepatol 2012; 24:37-41.
15. Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther 2007; 26:879-887.
16. den Hoed CM, van Eijck BC, Capelle LG, van Dekken H, Biermann K, Siersema PD, et al. The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. Eu J Cancer 2011; 47:1211-1218.
17. Weck MN, Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev 2006; 15: 1083-1094.
18. Feldman RA, Evans SJ. Accuracy of diagnostic methods used for epidemiological studies of Helicobacter pylori. Aliment Pharmacol Ther 1995; 9 (Suppl 2):21-31.
19. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009; 24:1587-1600.
20. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection - the Maastricht IV/ Florence Consensus Report. Gut 2012; 61:646-664.
21. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005; 54:764-768.
22. Kudo T, Kakizaki S, Sohara N, Onozato Y, Okamura S, Inui Y, et al. Analysis of ABC (D) stratification for screening patients with gastric cancer. World J Gastroenterol 2011; 17:4793-4798.
23. Miki K. Gastric cancer screening by combined assay for serum anti- Helicobacter pylori IgG antibody and serum pepsinogen levels - 'ABC method'. Proc Jpn Acad Ser B Phys Biol Sci 2011; 87:405-414.
24. Misins J, Rozite S, Sivins A, Krumins V, Boka V, Vikmanis U, et al. Incidence of gastric cancer in Latvia in 1980-2007. In a gate to the future of gastric cancer treatment. Proceedings of the 9th International Gastric Cancer Congress; 20-23 April 2011; Seoul, Korea. Pp. 159-199.
25. De Vries AC, Meijer GA, Looman CW, Casparie MK, Hansen BE, van Grieken NC, et al. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007; 56:1665-1670.
26. Hishida A, Matsuo K, Goto Y, Naito M,Wakai K, Tajima K, et al. Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobacter pylori seropositivity, gastric atrophy and gastric cancer in Japanese. BMC Gastroenterol 2009; 9:51.
27. Goto Y, Hishida A, Matsuo K, Tajima K, Morita E, Naito M, et al. PRKCH gene polymorphism is associated with the risk of severe gastric atrophy. Gastric Cancer 2010; 13:90-94.
28. de Vries AC, Kuipers EJ. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies. Helicobacter 2007; 12 (Suppl 2):22-31.
29. Sonnenberg A. Time trends of mortality from gastric cancer in Europe. Dig Dis Sci 2011; 56:1112-1118.
30. Genta RM. Gastric cancer: a well-behaved Helicobacter pylori-related disease? Dig Dis Sci 2011; 56:923-925.
31. Webb PM, Hengels KJ, Moller H, Newell DG, Palli D, Elder JB, et al. The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group. Gastroenterology 1994; 107:1335-1344.
32. Bures J, Kopacova M, Koupil I, Vorisek V, Rejchrt S, Beranek M, et al. Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter 2006; 11:56-65.
33. Dahlerup S, Andersen RC, Nielsen BS, Schjodt I, Christensen LA, Gerdes LU, et al. First-time urea breath tests performed at home by 36,629 patients: a study of Helicobacter pylori prevalence in primary care. Helicobacter 2011; 16:468-474.
34. Yamaoka M, Nakajima S. Prevalence of subjects at a high or very high risk of gastric cancer in Japan. Gut Liver 2009; 3:95-100.
35. Venerito M, Wex T, Malfertheiner P. Helicobacter pylori related and nonrelated lesions in the stomach. Minerva Gastroenterol Dietol 2011; 57: 395-403.
36. Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol 2012; 18:1279-1285.
37. Ekesbo R, Toth E, Fork FT, Held M, Nilsson I, Wadstrom T, et al. Chronic Helicobacter pylori infection in a population in southern Sweden analysed by histopathology, immunoblot and ELISA serology. Eur J Gastroenterol Hepatol 2006; 18:589-593.
38. Brenner H, Rothenbacher D, Weck MN. Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. Int J Cancer 2007; 121:2782-2786.
39. Miki K, Fujishiro M. Cautious comparison between east and west is necessary in terms of the serum pepsinogen test. Dig Endosc 2009; 21:134-135.
40. Hishida A, Matsuo K, Goto Y, Hamajima N. Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions. World J Gastrointest Oncol 2010; 2:369-379.
41. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Barbosa J, Guilherme M, Moreira-Dias L, et al. Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Neoplasia 2004; 6:449-456.
42. Seyda T, Derya C, Fusun A, Meliha K. The relationship of Helicobacter pylori positivity with age, sex, and ABO/Rhesus blood groups in patients with gastrointestinal complaints in Turkey. Helicobacter 2007; 12:244-250.